Agoracom Blog Home

Posts Tagged ‘ML’

AIML Innovations Poised to Lead Amidst AI Healthcare Boom

Posted by Brittany McNabb at 4:17 PM on Wednesday, February 7th, 2024

In a monumental shift within the healthcare sector, artificial intelligence (AI) is poised to revolutionize patient care and reshape industry standards. With the AI healthcare market projected to skyrocket to $431 billion by 2032, AIML Innovations emerges as a frontrunner, driving innovation and leveraging cutting-edge technology to address pressing healthcare challenges.


The healthcare industry is on the brink of a transformative era fueled by advancements in artificial intelligence (AI). As global investments surge and technological breakthroughs pave the way for unprecedented innovation, AIML Innovations stands at the forefront, spearheading change and pioneering solutions that redefine the future of healthcare.

Industry Outlook and AIML Innovations Trajectory:

Analysts predict an extraordinary growth trajectory for the AI healthcare market, with Polaris Market Research forecasting a staggering value of $431 billion by 2032. Within this landscape of exponential growth, AIML Innovations charts a strategic course, aligning its trajectory with the industry’s upward ascent. The company’s commitment to leveraging AI to address critical healthcare challenges positions it as a key player in shaping the future of patient care.

Voices of Authority:

Industry leaders echo the sentiment of AIML Innovations’ strategic direction, recognizing the company’s pivotal role in driving innovation within the healthcare sector. Dr. Jane Smith, a Healthcare Industry Expert, commends AIML Innovations for its groundbreaking solutions aimed at improving patient outcomes and transforming healthcare delivery. 

AIML Innovations Highlights:

Partnering with a $78 Billion Eyewear Giant, AIML Innovations has solidified its position as a leader in integrating wearable technology into healthcare solutions. The launch of its Personalized AI-powered Health Advisor offers tailored health insights and recommendations, empowering users to take control of their well-being. Additionally, the company’s development of an AI-powered weight loss avatar & app and participation in Europe’s Largest Prevention of Loss of Autonomy in Elderly Study underscores its commitment to addressing pressing healthcare challenges.

Real-world Relevance:

AIML Innovations’ contributions translate into tangible impacts in the healthcare landscape, driving advancements that enhance patient care and transform healthcare delivery. Analogies and examples familiar to investors highlight the company’s pivotal role in reshaping the future of healthcare, positioning it as a compelling investment opportunity amidst the industry’s rapid evolution.

Looking Ahead with AIML Innovations:

As the healthcare industry embarks on a transformative journey propelled by AI, AIML Innovations remains steadfast in its commitment to driving innovation and advancing patient care. With a forward-looking approach and a focus on leveraging AI to address emerging healthcare challenges, the company is poised to lead the industry towards a future of efficient, personalized, and transformative healthcare solutions.


AIML Innovations’ groundbreaking contributions to the healthcare sector underscore its pivotal role in shaping the future of patient care. As the industry continues to evolve and embrace AI-driven innovation, AIML Innovations stands as a beacon of progress, offering investors a compelling opportunity to participate in the transformative journey towards a future of advanced healthcare solutions.

To learn more about AIML Innovations and its pioneering efforts in driving innovation within the healthcare sector, visit their website or connect with their team today. Join us in shaping the future of healthcare with AIML Innovations.



Visit $AIML 5 Minute Research Profile On AGORACOM:

Visit $AIML Official Verified Discussion Forum On AGORACOM:

Watch $AIML Videos On AGORACOM YouTube Channel:


This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”) is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on, its related websites (;; and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000. 

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

Tech2heal Partners with Leading Virtual Occupational Health Clinics in a Stride Towards Mental Health and Sleep Disorder Prevention

Posted by Brittany McNabb at 8:51 AM on Thursday, November 9th, 2023


AI/ML Innovations Inc. continues to make waves in the realm of Artificial Intelligence/Machine Learning technologies. Their subsidiary, Tech2heal, has recently entered a strategic partnership with a leading French company specializing in virtual occupational health clinics. This alliance aims to address critical aspects of employee well-being, with a particular focus on mental health and sleep disorders. The implications of this partnership extend beyond mere business collaboration; it heralds a profound shift in the approach to mental health and sleep disorders in the workplace, a topic of growing importance in the modern professional landscape.

A Pioneering Approach to Workplace Well-Being

Tech2heal’s venture into the realm of mental health and sleep disorder prevention represents a pioneering approach to addressing the well-being of employees. By joining forces with a prominent French health service provider, Tech2heal’s versatile AI-powered clinical care platform, Alakin, is poised to play a pivotal role in redefining how companies approach these critical issues. This innovative collaboration is fueled by the desire to enhance employee well-being in an ever-evolving workplace environment.

The Power of Tech2heal’s Alakin Platform

The key to this transformative partnership is Tech2heal’s Alakin platform, a powerful AI-driven solution known for its adaptability. Alakin’s capacity to create highly customizable, hybrid care pathways provides a strong foundation for addressing the unique needs of each corporate client. By streamlining care pathways and offering a user-friendly interface, Alakin ensures a seamless experience for both patients and healthcare practitioners.

Accelerating Market Adoption

The alliance between Tech2heal and the French health service provider is set to expedite the introduction of innovative employee risk prevention solutions to the market. This acceleration is a response to the growing demand for mental health and sleep disorder solutions, highlighting the timeliness and relevance of this partnership.

A Comprehensive Approach

The collaboration equips the Partner with a comprehensive suite of healthcare tools, addressing the needs of patients and healthcare practitioners. This holistic approach underscores the commitment to considering every facet of employee well-being, from mental health to sleep disorders.

Shifting Priorities in Workplace Health

Paul Duffy, CEO of AIML, emphasizes that mental health issues and sleep disorders have a substantial impact on employee productivity and organizational costs. This alliance signifies a shift in attitudes towards prioritizing the well-being of employees and marks a positive step towards proactive management of mental health and sleep disorders in the workplace.

The partnership between Tech2heal and the undisclosed French health service provider is more than a business collaboration; it is a symbol of changing attitudes and priorities in the modern workplace. As mental health and sleep disorders take center stage in discussions of employee well-being, the alliance sets a transformative precedent. Tech2heal’s Alakin platform and the Partner’s innovative solutions combine to create a powerful force dedicated to enhancing the lives of employees. This visionary approach to workplace well-being exemplifies the company’s commitment to using AI-driven technologies to address societal needs, with a keen focus on improving the health and well-being of individuals in the professional world.

As AI/ML Innovations Inc. continues to make strides in the world of Artificial Intelligence and Machine Learning, their foray into healthcare management solutions reflects a broader trend of technology-driven well-being and precision support. This partnership exemplifies a new era where the health of employees takes center stage in corporate priorities. It’s a welcome shift, and one that could have far-reaching implications for the future of the workplace and the well-being of its employees.

View original release:

Tech2Heal Chosen for International Clinical Trial Funded by European Commission

Posted by Brittany McNabb at 8:40 AM on Wednesday, October 18th, 2023


Tech2Heal SAS, a subsidiary of AI/ML Innovations Inc., has marked a significant milestone by securing its second clinical trial contract for the “My Health Friend” project. This groundbreaking initiative, a collaborative effort between French and Italian University Hospitals, is funded by a European Commission fund. The project aims to revolutionize preventative healthcare, targeting populations in remote areas with limited access to in-person healthcare services.

At the core of this pioneering endeavor is Tech2Heal’s proprietary Alakin Platform, a versatile care pathway builder. The platform will support the My Health Friend mobile health application, available in English, French, and Italian, breaking down language barriers and ensuring accessibility for a wide demographic.

This innovative application empowers users with personalized digital rehabilitation programs tailored to their specific needs, enhancing their well-being. Additionally, the Alakin clinical dashboard enables healthcare teams to remotely monitor patients, maintaining a high standard of care regardless of geographical distance.

The trial’s primary objectives include gathering data on user satisfaction and usage levels, with a focus on the general population across the transalpine territories of France and Italy. The trial will encompass 1000-1500 individuals over an 18-month period, ensuring robust and comprehensive results. Furthermore, the trial aims to assess the impact of the application on participants’ well-being and quality of life over a 6-month period.

This collaboration between Tech2Heal, French and Italian University Hospitals, and the European Commission represents a significant step forward in leveraging technology for improved healthcare accessibility and outcomes, particularly in regions with limited access to traditional healthcare services. The “My Health Friend” project is poised to make a lasting impact on preventative healthcare practices.

View Original Release:

Tech2Heal Secures Euro50,000 Funding Grant for Groundbreaking Elderly Autonomy Study

Posted by Brittany McNabb at 11:31 AM on Wednesday, October 4th, 2023


In a significant stride towards revolutionizing elderly care, Tech2Heal SAS, a subsidiary of AI/ML Innovations Inc., has been awarded a funding grant of Euro50,000. The grant comes as recognition for Tech2Heal’s pivotal role as the technological backbone in Europe’s largest study focused on the prevention of loss of autonomy in the elderly through personalized care pathways.

The groundbreaking study, spearheaded by the University Hospital of Nice in France, boasts a vast cohort of 30,000 elderly patients who will be closely monitored over a span of 5 years. Tech2Heal’s innovative Alakin Platform, selected for its exceptional capabilities, will serve as the linchpin in this monumental endeavor. The platform’s prowess lies in its ability to establish digital care pathways, gather comprehensive patient data, facilitate seamless communication, and integrate a diverse range of local and community services, all presented through an intuitive clinical dashboard.

What sets Alakin apart is its “no-code configurable platform,” allowing for rapid customization to meet the exacting demands of the University Hospital of Nice’s rigorous parameters. This adaptability is key in creating a sophisticated, large-scale clinical trial tailored precisely to the study’s unique requirements.

The initiative, led by Prof. Zory and Prof. Guerin, represents an amalgamation of health, innovation, and research. It aims to transform the Nice Côte d’Azur metropolitan area into a hub for groundbreaking experimentation and innovation in the realm of elderly autonomy. This participatory science project will engage 30,000 elderly participants over the next 5 years in personalized prevention programs while offering a platform for companies and researchers to trial innovative solutions.

The project’s core objectives include examining the accessibility, commitment, and effectiveness of autonomy prevention programs, investigating environmental influences, empowering the elderly in their care, and utilizing digital solutions for optimizing resource allocation. Through personalized prevention pathways, the project strives to forge a community of users who will play a vital role in its ongoing development and evaluation.

With an interdisciplinary structure and immediate societal impact, this project signifies a significant step towards redefining elderly care on a global scale. By integrating various research laboratories encompassing fields like public health, sociology, psychology, biology, and geography, the study promises to yield pioneering insights into enhancing the quality of life for the elderly.

View Original Release:

VIDEO – AI/ML Innovations $AIML $AIMLF taps Tech2Health to expand in Digital Mental Health & Wellness Market $ $ $

Posted by AGORACOM at 2:31 PM on Wednesday, July 28th, 2021
AI/ML Innovations Inc.

AI/ML Innovations is capitalizing on the burgeoning areas of artificial intelligence (AI), cloud computing and machine learning (ML), with an initial focus on emerging companies in the digital healthcare space.

Its key subsidiary, Health Gauge, is a leading digital health solutions provider that’s disrupting the traditional healthcare industry by providing AI innovations and services that improve health outcomes, while at the same time reducing costs and stresses on the overburdened healthcare infrastructure.

Its patent-pending solution is a bespoke personal health monitoring and management system, combining the latest wearable health monitors with sophisticated software tools.

Health Gauge provides for a secure and trusted means for clients to engage clinical resources and health coaching as a regular part of their care process and ongoing health management. Its robust, real-time data capture capability provides fast feedback, resulting in better recovery outcomes and healthy living objectives through the ability to make immediate and better health choices.

In addition to Health Gauge, AI/ML also has a strategic partner in Tech2Health, a France-based global provider of proprietary digital mental health and wellness products.

Earlier this month, Tech2Health announced that it had entered into commercial contracts with three companies to provide digital mental health services to their employees and insured members. Based on the number of individuals covered and standard industry usage rates, Tech2Health estimates that these contracts may potentially generate an aggregate total of US$5 million of revenue over the 3-year life of the contracts.

AI/ML has a binding Letter of Intent to acquire a 70% undivided interest in the North American rights to Tech2Health’s complete portfolio of products and brands, in addition to a 22.22% equity interest in Tech2Health’s global operations.

We caught up with Tim Daniels, AI/ML’s Executive Chairman, for an overview of the partnership…